MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
-41.6%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$69.4M
AUM Growth
+$69.4M
(-44%)
Cap. Flow
-$573K
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
2
Closed
–
Top Buys
| 1 |
Werewolf Therapeutics
HOWL
|
$25K |
Top Sells
| 1 |
Repare Therapeutics
RPTX
|
$555K |
| 2 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$43.3K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Entrada Therapeutics
TRDA
$208M
| $39.6M | 57.04% | 4,381,062 | – | – |
|
2
iTeos Therapeutics
ITOS
| $16.4M | 23.55% | 2,738,785 | – | – |
|
3
Dyne Therapeutics
DYN
$1.92B
| $7.14M | 10.28% | 682,376 | – | – |
|
|
4
Werewolf Therapeutics
HOWL
$59.9M
| $4.19M | 6.03% | 4,309,860 +25,688 | +0.6% | +$25K |
|
|
5
Repare Therapeutics
RPTX
$71.7M
| $1.11M | 1.59% | 1,121,318 -562,389 | -33% | -$555K |
|
|
ADAP
6
Adaptimmune Therapeutics
ADAP
$15.6M
| $1.05M | 1.51% | 5,335,715 -219,746 | -4% | -$43.3K |
|